| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/EDE.0B013E318176B8AD |
| P698 | PubMed publication ID | 18496468 |
| P50 | author | Markku Heliövaara | Q61457966 |
| Jukka Montonen | Q64495937 | ||
| P2093 | author name string | Harri Rissanen | |
| Paul Knekt | |||
| Antti Reunanen | |||
| Tommi Härkänen | |||
| Jukka Marniemi | |||
| Maarit Laaksonen | |||
| Catharina Mattila | |||
| P433 | issue | 5 | |
| P921 | main subject | type 2 diabetes | Q3025883 |
| vitamin | Q34956 | ||
| vitamin D | Q175621 | ||
| P304 | page(s) | 666-671 | |
| P577 | publication date | 2008-09-01 | |
| P1433 | published in | Epidemiology | Q5382707 |
| P1476 | title | Serum vitamin D and subsequent occurrence of type 2 diabetes | |
| P478 | volume | 19 |
| Q36352583 | 25(OH)D3 and cardiovascular risk factors in female nonhuman primates |
| Q36263645 | 25-Hydroxyvitamin D Status and Risk for Colorectal Cancer and Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Epidemiological Studies |
| Q92555910 | 25-Hydroxyvitamin D and the risk of incident diabetes in Hong Kong Chinese |
| Q35830979 | 25-Hydroxyvitamin D deficiency is associated with fatal stroke among whites but not blacks: The NHANES-III linked mortality files. |
| Q37404364 | A liquid chromatography/tandem mass spectrometry method for determination of 25-hydroxy vitamin D2 and 25-hydroxy vitamin D3 in dried blood spots: a potential adjunct to diabetes and cardiometabolic risk screening |
| Q35740577 | A prospective observational study of all-cause mortality in relation to serum 25-OH vitamin D3 and parathyroid hormone levels in patients with type 2 diabetes. |
| Q37716737 | Altered glucose metabolism rather than naive type 2 diabetes mellitus (T2DM) is related to vitamin D status in severe obesity |
| Q36975760 | American College of Endocrinology Pre-Diabetes Consensus Conference: part three |
| Q39980921 | Assessment of vitamin D levels in type 1 and type 2 diabetes patients: Results from metaanalysis |
| Q38793708 | Association between serum 25(OH)D3 and cardiovascular morbidity and mortality in people with Type 2 diabetes: a community-based cohort study. |
| Q92402739 | Association between serum 25-hydroxyvitamin D concentrations and metabolic syndrome in the middle-aged and elderly Chinese population in Dalian, northeast China: A cross-sectional study |
| Q51361346 | Association of serum 25-hydroxyvitamin D with type 2 diabetes and markers of insulin resistance in a general older population in Finland. |
| Q34879819 | Association of vitamin D and vitamin D receptor gene polymorphisms with chronic inflammation, insulin resistance and metabolic syndrome components in type 2 diabetic Egyptian patients |
| Q36626836 | Association of vitamin D deficiency with incidence of type 2 diabetes in high-risk Asian subjects |
| Q91792480 | Association of vitamin D receptor gene polymorphism (VDR) with vitamin D deficiency, metabolic and inflammatory markers in Egyptian obese women |
| Q35988205 | Associations between Vitamin D Status and Type 2 Diabetes Measures among Inuit in Greenland May Be Affected by Other Factors |
| Q34230911 | Associations of serum 25-hydroxyvitamin D and components of the metabolic syndrome in obese adolescent females |
| Q33602257 | Associations of serum concentrations of 25-hydroxyvitamin D and parathyroid hormone with surrogate markers of insulin resistance among U.S. adults without physician-diagnosed diabetes: NHANES, 2003-2006 |
| Q87562522 | Bioavailability of vitamin D2 from enriched mushrooms in prediabetic adults: a randomized controlled trial |
| Q36782774 | Blood 25-hydroxy vitamin D levels and incident type 2 diabetes: a meta-analysis of prospective studies |
| Q38004818 | Circulating 25-hydroxyvitamin D concentration and the risk of type 2 diabetes: results from the European Prospective Investigation into Cancer (EPIC)-Norfolk cohort and updated meta-analysis of prospective studies |
| Q36782698 | Decreased serum concentrations of 25-hydroxycholecalciferol are associated with increased risk of progression to impaired fasting glucose and diabetes |
| Q35043736 | Diabetes and the risk of developing Parkinson's disease in Denmark. |
| Q36449234 | Diabetes prevalence is associated with serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D in US middle-aged Caucasian men and women: a cross-sectional analysis within the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial |
| Q46165508 | Diabetes, falls and fractures. |
| Q47736647 | Dietary program and physical activity impact on biochemical markers in patients with type 2 diabetes: A systematic review. |
| Q84389541 | Does vitamin D status contribute to caveolin-1-mediated insulin sensitivity in skeletal muscle? |
| Q89440931 | Effect of Vitamin D supplementation on body composition and cardiorespiratory fitness in overweight men-a randomized controlled trial |
| Q35225404 | Effect of serum 25-hydroxyvitamin D on risk for type 2 diabetes may be partially mediated by subclinical inflammation: results from the MONICA/KORA Augsburg study |
| Q36637934 | Effect of serum 25-hydroxyvitamin D3 on insulin resistance and β-cell function in newly diagnosed type 2 diabetes patients |
| Q36564584 | Effect of vitamin D on insulin resistance and anthropometric parameters in Type 2 diabetes; a randomized double-blind clinical trial |
| Q34225331 | Effect of vitamin D supplementation on glycaemic control and insulin resistance: a systematic review and meta-analysis. |
| Q35915364 | Effects of vitamin D supplementation on endothelial function: a systematic review and meta-analysis of randomised clinical trials |
| Q37622507 | Epidemiology of vitamin D in health and disease |
| Q64911485 | Evaluation of HbA1C and serum levels of vitamin D in diabetic patients. |
| Q37095081 | Extraskeletal effects and manifestations of Vitamin D deficiency |
| Q40707205 | Fatty liver score and 15-year incidence of type 2 diabetes |
| Q35749555 | Focus on vitamin D, inflammation and type 2 diabetes |
| Q92805385 | FokI polymorphism in vitamin D receptor gene: Differential expression of TNFα in peripheral mononuclear cells of type 2 diabetic subjects |
| Q37384029 | Gastric dysmotility and low serum vitamin D levels in patients with gastroparesis |
| Q36560217 | High-dose vitamin D supplementation in people with prediabetes and hypovitaminosis D |
| Q92432071 | IMPACT OF VITAMIN D DEFICIENCY ON COGNITIVE FUNCTIONS IN TYPE 2 DIABETIC PATIENTS |
| Q47732110 | Improvements in peripheral vascular function with vitamin D treatment in deficient adolescents with type 1 diabetes |
| Q33716852 | In defense of the sun: An estimate of changes in mortality rates in the United States if mean serum 25-hydroxyvitamin D levels were raised to 45 ng/mL by solar ultraviolet-B irradiance |
| Q92307608 | Indicators of Quality of Clinical Care for Type 2 Diabetes Patients in Primary Health Care Centers in Qatar: A Retrospective Analysis |
| Q47740568 | Is Hypovitaminosis D Related to Incidence of Type 2 Diabetes and High Fasting Glucose Level in Healthy Subjects: A Systematic Review and Meta-Analysis of Observational Studies. |
| Q36187648 | Is vitamin D status relevant to metabolic syndrome? |
| Q34583291 | Lack of association between 25(OH)D levels and incident type 2 diabetes in older women |
| Q39830481 | Lack of effect of subtherapeutic vitamin D treatment on glycemic and lipid parameters in Type 2 diabetes: A pilot prospective randomized trial |
| Q38114458 | Less than adequate vitamin D status and intake in Latin America and the Caribbean:a problem of unknown magnitude. |
| Q35592374 | Links between Vitamin D Deficiency and Cardiovascular Diseases |
| Q34983896 | Low prevalence of vitamin D deficiency in elderly Afro-Caribbean men. |
| Q48008860 | Low serum 25-hydroxyvitamin D level predicts progression to type 2 diabetes in individuals with prediabetes but not with normal glucose tolerance |
| Q37176643 | Multivariate path analysis of serum 25-hydroxyvitamin D concentration, inflammation, and risk of type 2 diabetes mellitus |
| Q51075109 | No association between 25-hydroxyvitamin D levels and prediabetes in Brazilian patients. A cross-sectional study. |
| Q43901101 | Non-linear association between 25-hydroxyvitamin D and the incidence of type 2 diabetes: a community-based nested case-control study. |
| Q33884078 | Non-skeletal health effects of vitamin D supplementation: A systematic review on findings from meta-analyses summarizing trial data |
| Q38186619 | Nutrients other than carbohydrates: their effects on glucose homeostasis in humans |
| Q58782777 | Nutritional issues in patients with obesity and cirrhosis |
| Q34229101 | Pattern of 25 hydroxy vitamin D status in North Indian people with newly detected type 2 diabetes: A prospective case control study |
| Q35879067 | Plasma 25-hydroxyvitamin D and progression to diabetes in patients at risk for diabetes: an ancillary analysis in the Diabetes Prevention Program |
| Q34084576 | Plasma 25-hydroxyvitamin D concentration and risk of incident type 2 diabetes in women |
| Q54936402 | Plasma 25-hydroxyvitamin D concentration and risk of type 2 diabetes and pre-diabetes: 12-year cohort study. |
| Q34287442 | Polymorphisms related to the serum 25-hydroxyvitamin D level and risk of myocardial infarction, diabetes, cancer and mortality. The Tromsø Study |
| Q33849334 | Predicted 25-hydroxyvitamin D score and incident type 2 diabetes in the Framingham Offspring Study |
| Q36433161 | Predictors of vitamin D biochemical status in a large sample of middle-aged male smokers in Finland |
| Q55259552 | Prevalence Pattern of Key Polymorphisms in the Vitamin D Receptor gene among Patients of Type 2 Diabetes Mellitus in Northeast India. |
| Q47171185 | Prevalence and association of metabolic syndrome and vitamin D deficiency among postmenopausal women in a rural block of West Bengal, India. |
| Q35405441 | Prospective associations of vitamin D with β-cell function and glycemia: the PROspective Metabolism and ISlet cell Evaluation (PROMISE) cohort study |
| Q34437639 | Rationale and design of the Vitamin D and Type 2 Diabetes (D2d) study: a diabetes prevention trial |
| Q51322161 | Relations of vitamin D status, gender and type 2 diabetes in middle-aged Caucasians. |
| Q88799890 | Relationship Between Vitamin D Deficiency and the Components of Metabolic Syndrome in Patients with Morbid Obesity, Before and 1 Year After Laparoscopic Roux-en-Y Gastric Bypass or Sleeve Gastrectomy |
| Q33938188 | Relationship between glycated hemoglobin and circulating 25-hydroxyvitamin D concentration in African American and Caucasian American men. |
| Q37247011 | Relationship between homeostasis model assessment of insulin resistance and beta cell function and serum 25-hydroxyvitamin D in non-diabetic Korean adults |
| Q37785398 | Review Article: Health benefit of increased serum 25(OH)D levels from oral intake and ultraviolet-B irradiance in the Nordic countries |
| Q36825786 | Role of vitamin d in cardiometabolic diseases |
| Q37423816 | Role of vitamin d in insulin secretion and insulin sensitivity for glucose homeostasis |
| Q59791175 | Serum 25(OH) vitamin D level and its relation to diabetic peripheral neuropathy in Egyptian patients with type 2 diabetes mellitus |
| Q44219847 | Serum 25(OH)D and incident type 2 diabetes: a cohort study. |
| Q36109114 | Serum 25(OH)D and type 2 diabetes association in a general population: a prospective study |
| Q33966808 | Serum 25-hydroxyvitamin D and insulin resistance in apparently healthy adolescents. |
| Q37705163 | Serum 25-hydroxyvitamin D concentration does not independently predict incident diabetes in older women |
| Q35080436 | Serum 25-hydroxyvitamin D concentrations in relation to cardiometabolic risk factors and metabolic syndrome in postmenopausal women |
| Q40660800 | Serum 25-hydroxyvitamin D level and incident type 2 diabetes in older men, the Osteoporotic Fractures in Men (MrOS) study. |
| Q46654466 | Serum 25-hydroxyvitamin D levels and incident diabetes mellitus type 2: a competing risk analysis in a large population-based cohort of older adults |
| Q35043732 | Serum 25-hydroxyvitamin D, calcium intake, and risk of type 2 diabetes after 5 years: results from a national, population-based prospective study (the Australian Diabetes, Obesity and Lifestyle study) |
| Q35043798 | Serum 25-hydroxyvitamin d levels and prediabetes among subjects free of diabetes |
| Q34012821 | Serum 25-hydroxyvitamin d levels are not associated with subclinical vascular disease or C-reactive protein in the old order amish |
| Q41581751 | Serum Vitamin D Concentrations Are Not Associated with Insulin Resistance in Swiss Adults |
| Q41056825 | Serum calcium and incident diabetes: an observational study and meta-analysis |
| Q42869397 | Serum concentrations of vitamin D and parathyroid hormone and prevalent metabolic syndrome among adults in the United States |
| Q34962536 | Serum vitamin D and the risk of Parkinson disease |
| Q39565953 | Serum vitamin D levels in office workers in a subtropical climate |
| Q37457135 | Serum vitamin D, parathyroid hormone levels, and carotid atherosclerosis |
| Q64903244 | Single Nucleotide Polymorphisms in the Vitamin D Receptor Gene (VDR) May Have an Impact on Acute Pancreatitis (AP) Development: A Prospective Study in Populations of AP Patients and Alcohol-Abuse Controls. |
| Q35828220 | Staphylococcus aureus nasal carriage is associated with serum 25-hydroxyvitamin D levels, gender and smoking status. The Tromsø Staph and Skin Study |
| Q22305327 | Systematic Review: Vitamin D and Cardiometabolic Outcomes |
| Q61811251 | The Association Between Vitamin D Status, Vitamin D Supplementation, Sunlight Exposure, and Parkinson's Disease: A Systematic Review and Meta-Analysis |
| Q42368235 | The Impact of Sex and 25(OH)D Deficiency on Metabolic Function in Mice. |
| Q40032248 | The association between vitamin D status and type 2 diabetes in a Thai population, a cross-sectional study |
| Q54938204 | The association of VDR polymorphisms and type 2 diabetes in older people living in community in Santiago de Chile. |
| Q92332819 | The effect of co supplementation of omega-3 and vitamin D on cardio metabolic risk factors and psychological distress in reproductive-aged women with prediabetes and hypovitaminosis D: a study protocol for a randomized controlled trial |
| Q39580164 | The effect of vitamin D3 and ketoconazole combination on VDR-mediated P-gp expression and function in human colon adenocarcinoma cells: implications in drug disposition and resistance |
| Q35916881 | The effects of intermittent vitamin D3 supplementation on muscle strength and metabolic parameters in postmenopausal women with type 2 diabetes: a randomized controlled study |
| Q37034916 | The effects of oral vitamin D on insulin resistance in pre-diabetic patients |
| Q35003735 | The relationship between serum 25-hydroxyvitamin D concentration, cardiorespiratory fitness, and insulin resistance in Japanese men. |
| Q35791100 | The relationship between vitamin D and the renin-angiotensin system in the pathophysiology of hypertension, kidney disease, and diabetes |
| Q43220008 | The relative importance of modifiable potential risk factors of type 2 diabetes: a meta-analysis of two cohorts |
| Q36783562 | The role of vitamin D in the metabolic homeostasis of diabetic bone |
| Q37704860 | Type 2 diabetes, PUFAs, and vitamin D: their relation to inflammation |
| Q35589823 | Vertebral fracture and cause-specific mortality: a prospective population study of 3,210 men and 3,730 women with 30 years of follow-up |
| Q64076601 | Vitamin D Insufficiency in Overweight and Obese Children and Adolescents |
| Q41422850 | Vitamin D Receptor Gene Polymorphisms Modify Cardiometabolic Response to Vitamin D Supplementation in T2DM Patients. |
| Q36945189 | Vitamin D Status Is Associated with Metabolic Syndrome in a Clinic-Based Sample of Hispanic Adults |
| Q36831195 | Vitamin D Status and Cardio-Metabolic Risk in Indian Postmenopausal Women |
| Q50074931 | Vitamin D and Type 2 Diabetes Mellitus |
| Q33976563 | Vitamin D and diabetes |
| Q87383723 | Vitamin D and diabetes |
| Q79774822 | Vitamin D and diabetes mellitus |
| Q38773655 | Vitamin D and diabetes mellitus: Causal or casual association? |
| Q38366390 | Vitamin D and insulin resistance |
| Q54073705 | Vitamin D and multiple sclerosis |
| Q38794281 | Vitamin D and pancreas: The role of sunshine vitamin in the pathogenesis of diabetes mellitus and pancreatic cancer |
| Q57385057 | Vitamin D and public health: an overview of recent research on common diseases and mortality in adulthood |
| Q38072776 | Vitamin D and type 2 diabetes mellitus (D2). |
| Q33789504 | Vitamin D and type 2 diabetes: a systematic review |
| Q37905859 | Vitamin D deficiency and disease risk among aboriginal Arctic populations |
| Q39986961 | Vitamin D deficiency and the risk of incident Type 2 diabetes |
| Q45934316 | Vitamin D deficiency is prevalent among idiopathic stone formers, but does correction pose any risk? |
| Q26864727 | Vitamin D deficiency: a new risk factor for type 2 diabetes? |
| Q37761905 | Vitamin D in older population: new roles for this 'classic actor'? |
| Q34461729 | Vitamin D status and cardiometabolic risk factors in the United States adolescent population |
| Q36508912 | Vitamin D status and coronary flow reserve measured by positron emission tomography: a co-twin control study |
| Q37397439 | Vitamin D status and its association with cardiometabolic risk factors in Korean adults based on a 2008-2010 Korean National Health and Nutrition Examination Survey |
| Q35043276 | Vitamin D status in relation to glucose metabolism and type 2 diabetes in septuagenarians |
| Q24200553 | Vitamin D supplementation for preventing recurrent stroke and vascular events in patients with stroke or transient ischaemic attack |
| Q94329966 | Vitamin D supplementation for preventing recurrent stroke and vascular events in patients with stroke or transient ischaemic attack |
| Q35692740 | Vitamin D supplementation in obese type 2 diabetes subjects in Ajman, UAE: a randomized controlled double-blinded clinical trial |
| Q26991851 | Vitamin D, calcium, and atherosclerotic risk: evidence from serum levels and supplementation studies |
| Q35405187 | Vitamin D, insulin secretion, sensitivity, and lipids: results from a case-control study and a randomized controlled trial using hyperglycemic clamp technique |
| Q39242378 | Vitamin D, sub-inflammation and insulin resistance. A window on a potential role for the interaction between bone and glucose metabolism. |
| Q38056255 | Vitamin D, type 2 diabetes and other metabolic outcomes: a systematic review and meta-analysis of prospective studies |
| Q36454137 | Vitamin D-rich marine Inuit diet and markers of inflammation - a population-based survey in Greenland. |
| Q33530770 | Vitamin D: newly discovered actions require reconsideration of physiologic requirements |
| Q37953480 | Vitamin d and metabolic syndrome risk factors: evidence and mechanisms |
| Q36540843 | Vitamin d deficiency and insulin resistance in normal and type 2 diabetes subjects |
| Q27022122 | Vitamins and type 2 diabetes mellitus |
Search more.